Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 120

Sort by

Sort Order Select

Journal Articles

Potently Cytotoxic Natural Killer Cell Potential Initially Emerges from Erythro-Myeloid Progenitors during Mammalian Development

Carissa Dege, PhD, Katherine H Fegan, MS, J Philip Creamer, IV, BA,BS, Melissa M Berrien-Elliott, PhD, Stephanie A. Luff, PhD, Julia A Wagner, PhD, Paul D. Kingsley, PhD, Kathleen E. McGrath, PhD, Todd A Fehniger, MD PhD, James Palis, MD, Christopher M. Sturgeon, PhD

Blood (2019) 134 (Supplement_1): 2464.

https://doi.org/10.1182/blood-2019-130347

Published: 2019

Journal Articles

Update on Risk Stratification Model of Smoldering Multiple Myeloma: A Systematic Review

Saad Ullah Malik, MD, Ahmad Abu-Hashyeh, MBBS, Muhammad Sardar, MD, Mohammad M Alhousani, Emilia Cindy Leigh, MD, Mohamed Suliman, MD, Abdul Mughees Rana, MD, Samson Teka, Eva Tackett, Faiz Anwer, MD

Blood (2019) 134 (Supplement_1): 5512.

https://doi.org/10.1182/blood-2019-132260

Published: 2019

Journal Articles

Matrix Metalloproteinase and Tissue Inhibitor of Metalloproteinases Is Associated with Multiple Myeloma Progression, Prognosis and Extramedullary Plasmacytoma

Blood (2018) 132 (Supplement 1): 3178.

https://doi.org/10.1182/blood-2018-99-113355

Published: 2018

Journal Articles

Microparticle Profiles in Patients with TTP Vs. ITP

Robert Forestal McCauley, BS, Robert A Ali, MD, Yonette Paul, MD MBBS, Miriam Yaniz, MS, ASCP, Martha Q. Gonzalez, MD MT, Wenche Jy, PhD, Lawrence L. Horstman, BS, Yeon S. Ahn, MD

Blood (2018) 132 (Supplement 1): 3749.

https://doi.org/10.1182/blood-2018-99-112963

Published: 2018

Journal Articles

Outcome of Soft-Tissue Plasmocytomas in Newly Diagnosed Multiple Myeloma Patients Treated with New Drugs

Blood (2018) 132 (Supplement 1): 3235.

https://doi.org/10.1182/blood-2018-99-111482

Published: 2018

Journal Articles

Definitive EMP and Pre-HSC Emerge in Myb-Null Murine Embryos and Retain Macrophage Potential

Kathleen E. McGrath, PhD, Jenna M Frame, PhD, Katherine H Fegan, MS, Emanuele Azzoni, PhD, Paul D. Kingsley, PhD, Anne D Koniski, MS, Seana C Catherman, BS, Marella De Bruijn, PhD, James Palis, MD

Blood (2018) 132 (Supplement 1): 2556.

https://doi.org/10.1182/blood-2018-99-118742

Published: 2018

Journal Articles

Ontogeny As a Critical Determinant of Natural Killer Cell Potential and Function

Carissa Dege, PhD, Kathleen E. McGrath, PhD, Melissa M Berrien-Elliott, PhD, Katherine H Fegan, MS, Julia Alexandra Wagner, BS, Todd A Fehniger, MDPhD, James Palis, MD, Christopher Sturgeon, PhD

Blood (2018) 132 (Supplement 1): 1271.

https://doi.org/10.1182/blood-2018-99-119812

Published: 2018

Journal Articles

Correlation of Circulating Microparticles with Coagulation and Fibrinolysis Is Healthy Individuals

Venencia Albert, PhD BSc, MSc, Arulselvi Subramanian, MDpathology, Hara Prasad Pati, MD

Blood (2018) 132 (Supplement 1): 4975.

https://doi.org/10.1182/blood-2018-99-120371

Published: 2018

Journal Articles

Cell Derived Microparticles (MP) in Different Phases of Thrombotic Thrombocytopenic Purpura (TTP) and Effect of Exchange Plasmapheresis (EPP) on Their Profiles

Robert A Ali, MD, Yonette Paul, MD MBBS, Robert Forestal McCauley, BS, Miriam Yaniz, MS, ASCP, Martha Q. Gonzalez, MD MT, Lawrence L. Horstman, BS, Wenche Jy, PhD, Yeon S. Ahn

Blood (2018) 132 (Supplement 1): 3736.

https://doi.org/10.1182/blood-2018-99-115651

Published: 2018

Journal Articles

Surveillance Functional Imaging Has Limited Role in Solitary Plasmacytomas: International Multi-Centre Study of Clinical Outcomes

Faye A Sharpley, MBBChir, MA, MRCP, MSc BA, Pedro Neffa, Fotis Panitsas, Jaimal Kothari, David Cutter, Roberta Shcolnik Szor, Manil Subesinghe, MBBS, MRCP, FRCR., Gracia Martinez, MD, Vanderson Rocha, MD PhD, Karthik Ramasamy

Blood (2017) 130 (Supplement 1): 5379.

https://doi.org/10.1182/blood.V130.Suppl_1.5379.5379

Published: 2017

Journal Articles

Validation of Dynamic Biomarker-Based Risk Progression Model for Smoldering Multiple Myeloma

Shebli Atrash, Myra M Robinson, MSPH, Amanda Aneralla, Taylor Brown, BS, MS, Reed Friend, MD, Chelsea Sprouse, Ami Ndiaye, Qing Zhang, PhD, Edward H Lipford, MD, Jared G Block, MD, Elton T Smith, MD, James T Symanowski, PhD, Belinda Rene Avalos, MD, Edward A Copelan, MD, Peter M. Voorhees, MD, Saad Z Usmani, MD, Manisha Bhutani, MD

Blood (2017) 130 (Supplement 1): 1779.

https://doi.org/10.1182/blood.V130.Suppl_1.1779.1779

Published: 2017

Journal Articles

Bortezomib, Lenalidomide and Dexamethasone (VRD-GEM) As Induction Therapy Prior Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM): Results of a Prospective Phase III Pethema/GEM Trial

Blood (2017) 130 (Supplement 1): 2017.

https://doi.org/10.1182/blood.V130.Suppl_1.2017.2017

Published: 2017

Journal Articles

Single-Cell Transcriptome Analysis of Embryonic Erythro-Myeloid Progenitor Cells Reveals Lineage Heterogeneity

Jacquelyn Lillis, MS, Kathleen E. McGrath, PhD, Seana C Catherman, BS, Michelle Zanche, MS, Balys Merlene, MS, John M Ashton, PhD, James Palis, MD

Blood (2017) 130 (Supplement 1): 3753.

https://doi.org/10.1182/blood.V130.Suppl_1.3753.3753

Published: 2017

Journal Articles

Transgenic Zebrafish Expressing the Human TEL-AML1 Oncogene Have Aberrant Developmental Myelopoiesis

Oscar Pena, Catherine Hockings, MBBChir, MA, FRCPath, MRCP, Gregorio Contento, Jasmine Rowell, Hatem Sabaawy, MD PhD, Tariq Enver, PhD, Elspeth M Payne, MD PhD

Blood (2016) 128 (22): 2711.

https://doi.org/10.1182/blood.V128.22.2711.2711

Published: 2016

Journal Articles

Overexpression of BCL9, a Wnt/β-Catenin Transcriptional Co-Activator, in Transgenic Mice Promotes Spontaneous Development of B-Cell Malignancies

Tomasz Sewastianik, PhD, Jianjun Zhao, MD PhD, Meng Jiang, MD, Peter S. Dennis, BS, Myles Brown, MD, Kwok Wong, MD, Ruben D. Carrasco, MD PhD

Blood (2016) 128 (22): 441.

https://doi.org/10.1182/blood.V128.22.441.441

Published: 2016

Journal Articles

Altered Endothelial Cells Properties and Platelets Activity in Treatment NaïVe Patients with Multiple Myeloma (MM ) and Non-Hodgkin Lymphoma (nHL): Association with Thromboembolic Complications

Lidia Usnarska-Zubkiewicz, prof., Maria Podolak-Dawidziak, prof., Urszula Zaleska-Dorobisz, prof., Magdalena Olszewska-Szopa, MD, Iwona Prajs, Jakub Debski, MD, Kazimierz Kuliczkowski, prof., Tadeusz Robak, MD PhD

Blood (2016) 128 (22): 5649.

https://doi.org/10.1182/blood.V128.22.5649.5649

Published: 2016

Journal Articles

Circulating Microparticles As Predictive Biomarkers of Acute Graft Versus Host Disease

Thiago Xavier Carneiro, MD, Daniella Gregolin Marrese, Melina Gonçalves dos Santos, PhD, Matheus Vescovi Gonçalves, MD PhD, Yana Sarkis Novis, MD, Edgar Gil Rizzatti, MD PhD, Vanderson Rocha, MD PhD, Alex Freire Sandes, MD PhD, Celso Arrais Rodrigues, MD PhD

Blood (2016) 128 (22): 5778.

https://doi.org/10.1182/blood.V128.22.5778.5778

Published: 2016

Journal Articles

Outcomes of Autologous Transplants for Patients with Multiple Myeloma and Concurrent Multiple Plasmacytomas

Seema Naik, MD, Paul J. Shaughnessy, MD, Behyar Zoghi, MDPhD, Jose C Cruz, MD, Carlos Bachier, MD

Blood (2015) 126 (23): 1973.

https://doi.org/10.1182/blood.V126.23.1973.1973

Published: 2015

Journal Articles

The Histone Methyltransferase Setd8 Is Essential for Mammalian Erythropoiesis

Jeffrey Malik, PhD, Michael Getman, MS, Jacquelyn Lillis, MS, Patrick G. Gallagher, MD, Laurie A Steiner, MD

Blood (2015) 126 (23): 3577.

https://doi.org/10.1182/blood.V126.23.3577.3577

Published: 2015

Journal Articles

Correlations of Red Cell-Derived Micropareticles (RMP) with Other MP Species in Hematological and Thrombotic Disorders

Lawrence L Horstman, BS, Wenche Jy, PhD, Mohamed EL Dinali, MD, Gabriel Tinoco, MD, Carlos Bidot, Jr., BS, Pamela B Dudkiewicz, MSN, ARNP, Yeon-Soong Ahn, MD

Blood (2015) 126 (23): 4723.

https://doi.org/10.1182/blood.V126.23.4723.4723

Published: 2015

NARROW

Potently Cytotoxic Natural Killer Cell Potential Initially Emerges from Erythro-Myeloid Progenitors during Mammalian Development

Update on Risk Stratification Model of Smoldering Multiple Myeloma: A Systematic Review

Matrix Metalloproteinase and Tissue Inhibitor of Metalloproteinases Is Associated with Multiple Myeloma Progression, Prognosis and Extramedullary Plasmacytoma

Microparticle Profiles in Patients with TTP Vs. ITP

Outcome of Soft-Tissue Plasmocytomas in Newly Diagnosed Multiple Myeloma Patients Treated with New Drugs

Definitive EMP and Pre-HSC Emerge in Myb-Null Murine Embryos and Retain Macrophage Potential

Ontogeny As a Critical Determinant of Natural Killer Cell Potential and Function

Correlation of Circulating Microparticles with Coagulation and Fibrinolysis Is Healthy Individuals

Cell Derived Microparticles (MP) in Different Phases of Thrombotic Thrombocytopenic Purpura (TTP) and Effect of Exchange Plasmapheresis (EPP) on Their Profiles

Surveillance Functional Imaging Has Limited Role in Solitary Plasmacytomas: International Multi-Centre Study of Clinical Outcomes

Validation of Dynamic Biomarker-Based Risk Progression Model for Smoldering Multiple Myeloma

Bortezomib, Lenalidomide and Dexamethasone (VRD-GEM) As Induction Therapy Prior Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM): Results of a Prospective Phase III Pethema/GEM Trial

Single-Cell Transcriptome Analysis of Embryonic Erythro-Myeloid Progenitor Cells Reveals Lineage Heterogeneity

Transgenic Zebrafish Expressing the Human TEL-AML1 Oncogene Have Aberrant Developmental Myelopoiesis

Overexpression of BCL9, a Wnt/β-Catenin Transcriptional Co-Activator, in Transgenic Mice Promotes Spontaneous Development of B-Cell Malignancies

Altered Endothelial Cells Properties and Platelets Activity in Treatment NaïVe Patients with Multiple Myeloma (MM ) and Non-Hodgkin Lymphoma (nHL): Association with Thromboembolic Complications

Circulating Microparticles As Predictive Biomarkers of Acute Graft Versus Host Disease

Outcomes of Autologous Transplants for Patients with Multiple Myeloma and Concurrent Multiple Plasmacytomas

The Histone Methyltransferase Setd8 Is Essential for Mammalian Erythropoiesis

Correlations of Red Cell-Derived Micropareticles (RMP) with Other MP Species in Hematological and Thrombotic Disorders

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only